Last 12 months
Inside the activity.
0 purchase rows · 50 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 23 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2024 Filed Jun 25, 2024 20:41 UTC |
Arbuckle Stuart ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-074770 · tm2418139-6_4seq1.xml · derivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date. Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 20:41 UTC |
Arbuckle Stuart ADirector
|
Exercise / conversionCommon Stock | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-074770 · tm2418139-6_4seq1.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 20:38 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-074768 · tm2418139-4_4seq1.xml · derivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date. Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 20:38 UTC |
TETRAULT LYNN A.Director
|
Exercise / conversionCommon Stock | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-074768 · tm2418139-4_4seq1.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:39 UTC |
GOOD JENNIFER LDirector
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073633 · tm2417588-2_4seq1.xml · derivative · entry 2 GOOD JENNIFER L · CIK 0001229245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:39 UTC |
GOOD JENNIFER LDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $41.39 | $0.00 |
DisclosureSEC source: 0001104659-24-073633 · tm2417588-2_4seq1.xml · derivative · entry 1 GOOD JENNIFER L · CIK 0001229245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2034-06-17 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:44 UTC |
MCGIRR DAVID W JDirector
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073637 · tm2417588-5_4seq1.xml · derivative · entry 2 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:44 UTC |
MCGIRR DAVID W JDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $41.39 | $0.00 |
DisclosureSEC source: 0001104659-24-073637 · tm2417588-5_4seq1.xml · derivative · entry 1 MCGIRR DAVID W J · CIK 0001219023 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2034-06-17 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:41 UTC |
Bedrosian Camille LDirector
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073634 · tm2417588-3_4seq1.xml · derivative · entry 2 Bedrosian Camille L · CIK 0001326969 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:41 UTC |
Bedrosian Camille LDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $41.39 | $0.00 |
DisclosureSEC source: 0001104659-24-073634 · tm2417588-3_4seq1.xml · derivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2034-06-17 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:43 UTC |
Mathers Edward TDirector
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-075835 · ownership.xml · derivative · entry 2 Mathers Edward T · CIK 0001328625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:43 UTC |
Mathers Edward TDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $41.39 | $0.00 |
DisclosureSEC source: 0000950170-24-075835 · ownership.xml · derivative · entry 1 Mathers Edward T · CIK 0001328625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2034-06-17 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:42 UTC |
JEAN CHRISTOPHEDirector
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073636 · tm2417588-4_4seq1.xml · derivative · entry 2 JEAN CHRISTOPHE · CIK 0001378435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:42 UTC |
JEAN CHRISTOPHEDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $41.39 | $0.00 |
DisclosureSEC source: 0001104659-24-073636 · tm2417588-4_4seq1.xml · derivative · entry 1 JEAN CHRISTOPHE · CIK 0001378435 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2034-06-17 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:38 UTC |
Arbuckle Stuart ADirector
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073631 · tm2417588-1_4seq1.xml · derivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:38 UTC |
Arbuckle Stuart ADirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $41.39 | $0.00 |
DisclosureSEC source: 0001104659-24-073631 · tm2417588-1_4seq1.xml · derivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2034-06-17 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:47 UTC |
TETRAULT LYNN A.Director
|
GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073638 · tm2417588-7_4seq1.xml · derivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 01:47 UTC |
TETRAULT LYNN A.Director
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $41.39 | $0.00 |
DisclosureSEC source: 0001104659-24-073638 · tm2417588-7_4seq1.xml · derivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2034-06-17 F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:21 UTC |
Shulman JosephChief Technical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,984 | $0.00 Strike: $6.80 | $0.00 |
DisclosureSEC source: 0001104659-24-060559 · tm2414300-1_4seq1.xml · derivative · entry 4 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,875 Underlying: Common Stock · 3,984 shares Expires 2032-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:21 UTC |
Shulman JosephChief Technical Officer
|
SaleCommon Stock | 500 | $39.10 | $19,551.00 |
DisclosureSEC source: 0001104659-24-060559 · tm2414300-1_4seq1.xml · nonDerivative · entry 3 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on May 5, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $39.05 to $40.0499. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:21 UTC |
Shulman JosephChief Technical Officer
|
SaleCommon Stock | 3,484 | $38.38 | $133,707.56 |
DisclosureSEC source: 0001104659-24-060559 · tm2414300-1_4seq1.xml · nonDerivative · entry 2 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 530 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on May 5, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $37.96 to $38.9599. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:21 UTC |
Shulman JosephChief Technical Officer
|
Exercise / conversionCommon Stock | 3,984 | $6.80 | $27,091.20 |
DisclosureSEC source: 0001104659-24-060559 · tm2414300-1_4seq1.xml · nonDerivative · entry 1 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 00:11 UTC |
Mazabraud YannEVP, Head of International
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-047957 · tm2411921-1_4seq1.xml · derivative · entry 6 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F8 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date. F8 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 00:11 UTC |
Mazabraud YannEVP, Head of International
|
GrantRestricted Stock Units · Derivative | 8,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-047957 · tm2411921-1_4seq1.xml · derivative · entry 5 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,905 Underlying: Common Stock · 8,905 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F7 · derivative.exercise_date: The restricted stock units vest in full on April 15, 2025. The restricted stock units have no expiration date. F7 · derivative.expiration_date: The restricted stock units vest in full on April 15, 2025. The restricted stock units have no expiration date. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 00:11 UTC |
Mazabraud YannEVP, Head of International
|
Disposition to issuerRestricted Stock Units · Derivative | 6,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-047957 · tm2411921-1_4seq1.xml · derivative · entry 4 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,874 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · kind: The restricted stock units were rescinded and cancelled by mutual agreement of the reporting person and Issuer. The reporting person received French-qualified restricted stock units on April 15, 2024 as consideration for the recission and cancellation of the unvested portion of the restricted stock previously received on February 9, 2022. F6 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 00:11 UTC |
Mazabraud YannEVP, Head of International
|
Disposition to issuerRestricted Stock Units · Derivative | 2,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-047957 · tm2411921-1_4seq1.xml · derivative · entry 3 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,031 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · kind: The restricted stock units were rescinded and cancelled by mutual agreement of the reporting person and Issuer. The reporting person received French-qualified restricted stock units on April 15, 2024 as consideration for the recission and cancellation of the unvested portion of the restricted stock previously received on February 11, 2021. F4 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. F4 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. Read SEC document |
| April 14, 2024 Filed Apr 17, 2024 00:11 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionRestricted Stock Units · Derivative | 10,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-047957 · tm2411921-1_4seq1.xml · derivative · entry 2 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,125 Underlying: Common Stock · 10,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date. Read SEC document |
| April 14, 2024 Filed Apr 17, 2024 00:11 UTC |
Mazabraud YannEVP, Head of International
|
Exercise / conversionCommon Stock | 10,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-047957 · tm2411921-1_4seq1.xml · nonDerivative · entry 1 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 00:00 UTC |
German Christopher PaulCorporate Controller & CAO
|
SaleCommon Stock | 368 | $41.76 | $15,367.68 |
DisclosureSEC source: 0001104659-24-043249 · tm2410989-1_4seq1.xml · nonDerivative · entry 2 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 795 F2 · kind: The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $41.55 to $41.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:55 UTC |
Shulman JosephChief Technical Officer
|
SaleCommon Stock | 18,235 | $40.34 | $735,599.90 |
DisclosureSEC source: 0001104659-24-037927 · tm249484-2_4seq1.xml · nonDerivative · entry 1 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $40.00 to $40.89. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:16 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
SaleCommon Stock | 9,066 | $39.33 | $356,565.78 |
DisclosureSEC source: 0001104659-24-037880 · tm249484-1_4seq1.xml · nonDerivative · entry 2 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,852 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $38.75 to $39.72. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:16 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
SaleCommon Stock | 9,169 | $38.22 | $350,439.18 |
DisclosureSEC source: 0001104659-24-037880 · tm249484-1_4seq1.xml · nonDerivative · entry 1 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,918 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $37.75 to $38.68. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 20, 2024 Filed Apr 4, 2024 00:00 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-043249 · tm2410989-1_4seq1.xml · derivative · entry 3 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,487 Underlying: Common Stock · 1,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The restricted stock units have vested or will vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 20, 2026 and March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date. F4 · derivative.expiration_date: The restricted stock units have vested or will vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 20, 2026 and March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date. Read SEC document |
| March 20, 2024 Filed Apr 4, 2024 00:00 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionCommon Stock | 1,163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-043249 · tm2410989-1_4seq1.xml · nonDerivative · entry 1 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 00:50 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
SaleCommon Stock | 15,515 | $39.22 | $608,498.30 |
DisclosureSEC source: 0001104659-24-036310 · tm249308-1_4seq1.xml · nonDerivative · entry 1 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,005 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $39.07 to $39.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 00:52 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
SaleCommon Stock | 15,515 | $39.22 | $608,498.30 |
DisclosureSEC source: 0001104659-24-036312 · tm249308-2_4seq1.xml · nonDerivative · entry 1 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,087 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $39.07 to $39.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 00:54 UTC |
Meeker David PDirector · President and CEO
|
SaleCommon Stock | 45,494 | $39.22 | $1,784,274.68 |
DisclosureSEC source: 0001104659-24-036316 · tm249308-4_4seq1.xml · nonDerivative · entry 1 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,605 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $39.04 to $39.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 00:57 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 15,515 | $39.22 | $608,498.30 |
DisclosureSEC source: 0001104659-24-036319 · tm249308-6_4seq1.xml · nonDerivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,939 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $39.04 to $39.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 00:56 UTC |
Shulman JosephChief Technical Officer
|
SaleCommon Stock | 15,515 | $39.22 | $608,498.30 |
DisclosureSEC source: 0001104659-24-036317 · tm249308-5_4seq1.xml · nonDerivative · entry 1 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,265 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $39.06 to $39.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 00:53 UTC |
Mazabraud YannEVP, Head of International
|
SaleCommon Stock | 16,000 | $39.22 | $627,520.00 |
DisclosureSEC source: 0001104659-24-036315 · tm249308-3_4seq1.xml · nonDerivative · entry 1 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,495 F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $39.10 to $39.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:01 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,200 | $0.00 Strike: $49.23 | $0.00 |
DisclosureSEC source: 0001104659-24-026158 · tm246920-4_4seq1.xml · derivative · entry 3 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,200 Underlying: Common Stock · 40,200 shares Expires 2034-02-15 F4 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:01 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 13,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-026158 · tm246920-4_4seq1.xml · derivative · entry 2 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,200 Underlying: Common Stock · 13,200 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:01 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantCommon Stock | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-026158 · tm246920-4_4seq1.xml · nonDerivative · entry 1 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,520 F1 · shares: The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:00 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantStock Option (Right to Buy) · Derivative | 67,000 | $0.00 Strike: $49.23 | $0.00 |
DisclosureSEC source: 0001104659-24-026154 · tm246920-1_4seq1.xml · derivative · entry 3 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2034-02-15 F4 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:00 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantRestricted Stock Units · Derivative | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-026154 · tm246920-1_4seq1.xml · derivative · entry 2 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:00 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantCommon Stock | 33,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-026154 · tm246920-1_4seq1.xml · nonDerivative · entry 1 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,602 F1 · shares: The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:02 UTC |
German Christopher PaulCorporate Controller & CAO
|
GrantStock Option (Right to Buy) · Derivative | 5,400 | $0.00 Strike: $49.23 | $0.00 |
DisclosureSEC source: 0001104659-24-026159 · tm246920-5_4seq1.xml · derivative · entry 2 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,400 Underlying: Common Stock · 5,400 shares Expires 2034-02-15 F3 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:02 UTC |
German Christopher PaulCorporate Controller & CAO
|
GrantRestricted Stock Units · Derivative | 7,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-026159 · tm246920-5_4seq1.xml · derivative · entry 1 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,225 Underlying: Common Stock · 7,225 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:03 UTC |
Meeker David PDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 259,000 | $0.00 Strike: $49.23 | $0.00 |
DisclosureSEC source: 0001104659-24-026162 · tm246920-7_4seq1.xml · derivative · entry 3 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,000 Underlying: Common Stock · 259,000 shares Expires 2034-02-15 F4 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 00:03 UTC |
Meeker David PDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-026162 · tm246920-7_4seq1.xml · derivative · entry 2 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.